Physician profile
Devendra Amin
NPI 1508847070
$57,375.89
in general payments reported to CMS, 2019-2025
9 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,734 · 2020: $13K · 2021: $671 · 2023: $9,146 · 2024: $26K · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $16K · Honoraria: $2,500 · Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,050.00 |
| Travel and Lodging | $16,032.71 |
| Honoraria | $2,500.00 |
| Food and Beverage | $688.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $53,481.23 | 2019-2024 | Vidas Nephrocheck, Filmarray Pneumonia Panel (Pneumo) |
| Fisher Scientific Company L.L.C. | $2,575.04 | 2024 | Procalcitonin |
| Becton, Dickinson and Company | $787.00 | 2025 | Hemosphere |
| Mallinckrodt Hospital Products INC. | $149.27 | 2025 | Terlivaz |
| Exthera Medical Corporation | $137.83 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $82.71 | 2019-2021 | |
| Insmed, INC. | $74.16 | 2023 | Arikayce |
| Medtronic, INC. | $69.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.65 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devendra Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.